Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : SMY - SAMSys Technologies Inc -- Ignore unavailable to you. Want to Upgrade?

To: Montana Wildhack who wrote (264)	3/15/2004 12:05:43 PM
From: Manx	Read Replies (1) \| Respond to of 342

RFID Plays Critical Role in Identifying the Flow of Counterfeit Drugs Across Borders, According to BearingPoint's Attilio Bellman Monday March 15, 11:02 am ET MCLEAN, Va., March 15 /PRNewswire-FirstCall/ -- Uniquely identifying all drug products for use in the United States with Radio Frequency Identification (RFID) tags will be key in combating the rise of counterfeit prescription drugs flowing across U.S. borders, according to Dr. Attilio Bellman at BearingPoint, Inc. (NYSE: BE - News), one of the world's largest business consulting and systems integration firms. (Logo: newscom.com ) The Food & Drug Administration has made a fundamental step towards a more secure pharmaceutical supply chain by publishing the "Combating Counterfeit Drugs" report, on February 18, 2004. The report suggests that the adoption and common use of reliable track-and-trace technology is feasible by 2007. Dr. Bellman will address this industry issue at the PharmaIT Summit, March 16-18, in New York, at the Javits Convention Center on March 16 at 2:00pm. PharmaIT Summit is attended by key decision-makers within the pharmaceutical enterprise for setting IT strategies and making purchases. To speak with Dr. Bellman, please contact Lizette Kodama at 212-954-2461 to schedule an in-person or phone interview. About BearingPoint, Inc. BearingPoint, Inc. (NYSE: BE - News) is one of the world's largest business consulting, systems integration and managed services firms serving Global 2000 companies, medium-sized businesses, government agencies and other organizations. We provide business and technology strategy, systems design, architecture, applications implementation, network infrastructure, systems integration and managed services. Our service offerings are designed to help our clients generate revenue, reduce costs and access the information necessary to operate their business on a timely basis. Based in McLean, Va., BearingPoint has been named by Fortune as one of America's Most Admired Companies in the computer and data services sector. For more information, visit the Company's website at www.BearingPoint.com.

To: Montana Wildhack who wrote (264)	3/20/2004 2:28:11 AM
From: twentyfirstcenturyfox	Respond to of 342

For this and for the Baird pdf link - thanks. You have raised the ongoing question for me. 1. to invest in EM or one of the other majors ( a US label manfr. looks attractively situated, to take advantage of the the Wallmart initiative). or 2. a small cap such as Samsys. I look at the past 12 month performance of SMY. I wish I had followed your strategy of reducing exposure to DMX and shifting in SMY. Congrats on that move. SMY is still not back to where I last exited at($4.50+). So, I continue to wait for it to prove it can mature past the development stage. Good luck, Fox.